Question 1

What is Cadila Pharmaceuticals?

Accepted Answer

Cadila Pharmaceuticals is a Entity.

Question 2

How often does Cadila Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 14 articles.

Question 3

When was Cadila Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Nov 19, 2025.

Question 4

When was Cadila Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on May 25, 2026.

Question 5

What is Cadila Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 12 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Cadila Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Cadila Pharmaceuticals?

Accepted Answer

New TB Vaccines Show Limited Efficacy (Apr 10, 2026, 6 articles).

Question 8

How did the "New TB Vaccines Show Limited Efficacy" event impact Cadila Pharmaceuticals?

Accepted Answer

Cadila Pharmaceuticals co-developed the Immuvac vaccine, which was tested in the PreVenTB trial for its safety and efficacy against tuberculosis.

Question 9

How did the "Sudeep Pharma IPO Launches" event impact Cadila Pharmaceuticals?

Accepted Answer

Cadila Pharmaceuticals is a marquee customer of Sudeep Pharma.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.